<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Hypofibrinolysis caused by increased plasminogen activator inhibitor 1 (PAI-1) has been implicated in the vasculopathy of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, typified by increased insulin, <z:chebi fb="105" ids="17234">glucose</z:chebi>, and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>However, short-term infusions of insulin have not increased PAI-1 in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesized that induction of increased insulin accompanied by increased <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> would increase PAI-1 </plain></SENT>
<SENT sid="3" pm="."><plain>Accordingly, 30% <z:chebi fb="105" ids="17234">glucose</z:chebi> and 10% Intralipid were infused for 6 h in ten <z:mpath ids='MPATH_458'>normal</z:mpath> lean individuals (54 +/- 3 years) resulting in increased insulin (42 +/- 5 microU/dl), <z:chebi fb="105" ids="17234">glucose</z:chebi> (200 +/- 24 mg/dl), and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (425 +/- 45 mg/dl), simulating changes in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast to results with infusion of saline alone (n = 16) and euglycemic-hyperinsulinemic clamps (n = 10, serum insulin = 89 +/- 7 microU/dl), PAI-1 in blood increased significantly 6 h after the <z:hpo ids='HP_0003674'>onset</z:hpo> of infusion (15 +/- 5 ng/ml, P &lt; 0.05 vs. baseline = 7.4 +/- 1.1, saline 6 h = 3.4 +/- 1.1, and insulin alone 6 h = 3.7 +/- 0.8) and remained elevated for an additional 6 h (combined infusion = 13.8 +/- 3.8 ng/ml, saline = 6.7 +/- 2 ng/ml, insulin alone = 7.8 +/- 1.7 ng/ml, P = 0.06) </plain></SENT>
<SENT sid="5" pm="."><plain>Our data suggest that combined <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo>, and <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> are likely to contribute to hypofibrinolysis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> by increasing the blood levels of PAI-1 </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, these results underscore the potential importance of modifying <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> as well as achieving glycemic and lipidemic control in individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>